BD Onclarity™ HPV Assay with extended genotyping

Learn more about the benefits of extended genotyping and the BD Onclarity™ HPV Assay, the only FDA-approved HPV test with extended genotyping, that identifies genotypes beyond 16 and 18, including 31.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Doctor and Patient reviewing IFU
Cervical Cancer | Webinars & Videos
Hear from an expert about self-collection in a healthcare setting
Fast Company op-ed
Cervical Cancer | News & Updates
POV: The U.S. healthcare system is failing Black and Latina women
ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31
Cervical Cancer | Webinars & Videos
ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31